Results 141 to 150 of about 231,766 (309)

Engineering Bacteria for Medicine: Delivery, Diagnosis, and Therapy

open access: yesiMetaMed, EarlyView.
ABSTRACT With rapid advances in synthetic biology and genetic engineering, genetically engineered bacteria (GEB) have emerged as a promising platform for biological therapy, addressing key limitations of conventional drug delivery systems and demonstrating significant clinical potential.
Shiyu Xia   +11 more
wiley   +1 more source

Oseltamivir-Resistant Pandemic (H1N1) 2009 in Patient with Impaired Immune System

open access: yesEmerging Infectious Diseases, 2010
Grant A. Hill-Cawthorne   +3 more
doaj   +1 more source

Metrnβ drives sepsis immunosuppression via macrophage reprogramming: A novel prognostic biomarker and therapeutic target

open access: yesInterdisciplinary Medicine, EarlyView.
Metrnβ serves as a novel prognostic biomarker for sepsis and that targeted blockade of the Metrnβ‐c‐Kit axis represents a promising therapeutic strategy for sepsis. Abstract Sepsis is a heterogeneous syndrome critically driven by immunosuppression, yet lacking personalized prognostic markers and therapeutic targets. Here, we provide evidence to support
Xiao Li   +15 more
wiley   +1 more source

Investigation of Specific IgG‐Secreting Cells in Congenital Toxoplasmosis: The TOXODIAG Study

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
This study addressed the difficulty of establishing a postnatal biological diagnosis of congenital toxoplasmosis, particularly in the absence of toxoplasmosis monitoring during pregnancy, as is the case in many countries. Our work presents an ELISPOT (Enzyme‐Linked Immunospot) method adapted for the detection of B lymphocytes primed to produce IgG ...
F. Migot‐Nabias   +28 more
wiley   +1 more source

Improving Linkage to the HCV Care Cascade in Nonspecialist Settings: Evaluation of the Performance and Triage Utility of the Elecsys HCV Duo Assay in Japan

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
In nonspecialist departments, most anti‐HCV–positive individuals do not proceed to RNA testing. The Elecsys HCV Duo assay simultaneously detects anti‐HCV antibodies and core antigen from a single blood draw and preferentially identifies patients with clinically meaningful viral loads.
Hiroko Setoyama   +23 more
wiley   +1 more source

Chagas Disease in Immunocompromised Patients

open access: yes
As Chagas disease remains prevalent in the Americas, it is important that healthcare professionals and researchers are aware of the screening, diagnosis, monitoring, and treatment recommendations for the populations of patients they care for and study ...
Bern, Caryn   +3 more
core   +1 more source

Maternal influenza vaccination during pregnancy and risk of autism spectrum disorder in the offspring

open access: yesJCPP Advances, EarlyView.
Abstract Background Vaccination has been proposed as a potential risk factor for autism spectrum disorder (ASD), contributing to public hesitancy and mistrust toward immunization. Influenza vaccination during pregnancy is considered safe and effective in preventing serious maternal complications and adverse birth outcomes associated with influenza ...
Shahar Neeman   +4 more
wiley   +1 more source

Incidence, contributing factors, and predictors of diagnostic errors in medical inpatients: A retrospective cohort study

open access: yesJournal of Hospital Medicine, EarlyView.
Abstract Background Diagnostic error is a major patient safety concern in hospitals, yet most studies have focused on selected high‐risk subgroups, leaving the broader general internal medicine inpatient population understudied. Objectives To determine the incidence, contributing factors, resulting harm, and predictors of diagnostic error in medical ...
Caterina E. Marx   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy